196 related articles for article (PubMed ID: 12374458)
1. A novel, complex heterozygous mutation within Gsalpha gene in patient with McCune-Albright syndrome.
Song HD; Chen FL; Shi WJ; Wang S; Zhang Q; Hu RM; Chen JL
Endocrine; 2002 Jul; 18(2):121-8. PubMed ID: 12374458
[TBL] [Abstract][Full Text] [Related]
2. Genetic diagnosis of multiple affected tissues in a patient with McCune-Albright syndrome.
Zhou J; Sun LH; Cui B; Song HD; Li XY; Ning G; Liu JM
Endocrine; 2007 Apr; 31(2):212-7. PubMed ID: 17873334
[TBL] [Abstract][Full Text] [Related]
3. A comparative study of fibrous dysplasia and osteofibrous dysplasia with regard to Gsalpha mutation at the Arg201 codon: polymerase chain reaction-restriction fragment length polymorphism analysis of paraffin-embedded tissues.
Sakamoto A; Oda Y; Iwamoto Y; Tsuneyoshi M
J Mol Diagn; 2000 May; 2(2):67-72. PubMed ID: 11272890
[TBL] [Abstract][Full Text] [Related]
4. Searching for Arg201 mutations in the GNAS1 gene in Italian patients with McCune-Albright syndrome.
de Sanctis L; Romagnolo D; Greggio N; Genitori L; Lala R; de Sanctis C
J Pediatr Endocrinol Metab; 2002; 15 Suppl 3():883-9. PubMed ID: 12199346
[TBL] [Abstract][Full Text] [Related]
5. Activating Gsalpha mutations: analysis of 113 patients with signs of McCune-Albright syndrome--a European Collaborative Study.
Lumbroso S; Paris F; Sultan C;
J Clin Endocrinol Metab; 2004 May; 89(5):2107-13. PubMed ID: 15126527
[TBL] [Abstract][Full Text] [Related]
6. Parental origin of Gsalpha mutations in the McCune-Albright syndrome and in isolated endocrine tumors.
Mantovani G; Bondioni S; Lania AG; Corbetta S; de Sanctis L; Cappa M; Di Battista E; Chanson P; Beck-Peccoz P; Spada A
J Clin Endocrinol Metab; 2004 Jun; 89(6):3007-9. PubMed ID: 15181091
[TBL] [Abstract][Full Text] [Related]
7. An activating Gs alpha mutation is present in fibrous dysplasia of bone in the McCune-Albright syndrome.
Shenker A; Weinstein LS; Sweet DE; Spiegel AM
J Clin Endocrinol Metab; 1994 Sep; 79(3):750-5. PubMed ID: 8077356
[TBL] [Abstract][Full Text] [Related]
8. Investigation of the GSalpha gene in the diagnosis of fibrous dysplasia.
Perdigão PF; Pimenta FJ; Castro WH; De Marco L; Gomez RS
Int J Oral Maxillofac Surg; 2004 Jul; 33(5):498-501. PubMed ID: 15183415
[TBL] [Abstract][Full Text] [Related]
9. McCune-Albright syndrome: a detailed pathological and genetic analysis of disease effects in an adult patient.
Vasilev V; Daly AF; Thiry A; Petrossians P; Fina F; Rostomyan L; Silvy M; Enjalbert A; Barlier A; Beckers A
J Clin Endocrinol Metab; 2014 Oct; 99(10):E2029-38. PubMed ID: 25062453
[TBL] [Abstract][Full Text] [Related]
10. Genetic and molecular aspects of McCune-Albright syndrome.
Lietman SA; Schwindinger WF; Levine MA
Pediatr Endocrinol Rev; 2007 Aug; 4 Suppl 4():380-5. PubMed ID: 17982384
[TBL] [Abstract][Full Text] [Related]
11. Potent constitutive cyclic AMP-generating activity of XLαs implicates this imprinted GNAS product in the pathogenesis of McCune-Albright syndrome and fibrous dysplasia of bone.
Mariot V; Wu JY; Aydin C; Mantovani G; Mahon MJ; Linglart A; Bastepe M
Bone; 2011 Feb; 48(2):312-20. PubMed ID: 20887824
[TBL] [Abstract][Full Text] [Related]
12. A highly sensitive polymerase chain reaction method detects activating mutations of the GNAS gene in peripheral blood cells in McCune-Albright syndrome or isolated fibrous dysplasia.
Lietman SA; Ding C; Levine MA
J Bone Joint Surg Am; 2005 Nov; 87(11):2489-94. PubMed ID: 16264125
[TBL] [Abstract][Full Text] [Related]
13. Fibrous Dysplasia/McCune-Albright Syndrome: Clinical and Translational Perspectives.
Robinson C; Collins MT; Boyce AM
Curr Osteoporos Rep; 2016 Oct; 14(5):178-86. PubMed ID: 27492469
[TBL] [Abstract][Full Text] [Related]
14. Activating mutation of GS alpha in McCune-Albright syndrome causes skin pigmentation by tyrosinase gene activation on affected melanocytes.
Kim IS; Kim ER; Nam HJ; Chin MO; Moon YH; Oh MR; Yeo UC; Song SM; Kim JS; Uhm MR; Beck NS; Jin DK
Horm Res; 1999; 52(5):235-40. PubMed ID: 10844413
[TBL] [Abstract][Full Text] [Related]
15. Activating mutations of the stimulatory G protein in the McCune-Albright syndrome.
Weinstein LS; Shenker A; Gejman PV; Merino MJ; Friedman E; Spiegel AM
N Engl J Med; 1991 Dec; 325(24):1688-95. PubMed ID: 1944469
[TBL] [Abstract][Full Text] [Related]
16. A case of McCune-Albright syndrome associated with Gs alpha mutation in the bone tissue.
Sargin H; Gozu H; Bircan R; Sargin M; Avsar M; Ekinci G; Yayla A; Gulec I; Bozbuga M; Cirakoglu B; Tanakol R
Endocr J; 2006 Feb; 53(1):35-44. PubMed ID: 16543670
[TBL] [Abstract][Full Text] [Related]
17. GNAS mutation detection is related to disease severity in girls with McCune-Albright syndrome and precocious puberty.
Wagoner HA; Steinmetz R; Bethin KE; Eugster EA; Pescovitz OH; Hannon TS
Pediatr Endocrinol Rev; 2007 Aug; 4 Suppl 4():395-400. PubMed ID: 17982386
[TBL] [Abstract][Full Text] [Related]
18. A disruptive mutation in exon 3 of the GNAS gene with albright hereditary osteodystrophy, normocalcemic pseudohypoparathyroidism, and selective long transcript variant Gsalpha-L deficiency.
Thiele S; Werner R; Ahrens W; Hoppe U; Marschke C; Staedt P; Hiort O
J Clin Endocrinol Metab; 2007 May; 92(5):1764-8. PubMed ID: 17299070
[TBL] [Abstract][Full Text] [Related]
19. An unusual presentation of McCune-Albright syndrome confirmed by an activating mutation of the Gs alpha-subunit from a bone lesion.
Malchoff CD; Reardon G; MacGillivray DC; Yamase H; Rogol AD; Malchoff DM
J Clin Endocrinol Metab; 1994 Mar; 78(3):803-6. PubMed ID: 8126161
[TBL] [Abstract][Full Text] [Related]
20. Increased IL-6-production by cells isolated from the fibrous bone dysplasia tissues in patients with McCune-Albright syndrome.
Yamamoto T; Ozono K; Kasayama S; Yoh K; Hiroshima K; Takagi M; Matsumoto S; Michigami T; Yamaoka K; Kishimoto T; Okada S
J Clin Invest; 1996 Jul; 98(1):30-5. PubMed ID: 8690800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
